Literature DB >> 19641101

Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.

H Martin Vordermeier1, Gillian S Dean, Ida Rosenkrands, Else M Agger, Peter Andersen, Daryan A Kaveh, R Glyn Hewinson, Philip J Hogarth.   

Abstract

Tuberculosis (TB) remains one of the most important infectious diseases of humans and animals. Mycobacterium bovis BCG, the only currently available TB vaccine, demonstrates variable levels of efficacy; therefore, a replacement or supplement to BCG is required. Protein subunit vaccines have shown promise but require the use of adjuvants to enhance their immunogenicity. Using the protective mycobacterial antigen Rv3019c, we have evaluated the induction of relevant immune responses by adjuvant formulations directly in the target species for bovine TB vaccines and compared these to responses induced by BCG. We demonstrate that two classes of adjuvant induce distinct immune phenotypes in cattle, a fact not previously reported for mice. A water/oil emulsion induced both an effector cell and a central memory response. A cationic-liposome adjuvant induced a central memory response alone, similar to that induced by BCG. This suggests that water/oil emulsions may be the most promising formulations. These results demonstrate the importance of testing adjuvant formulations directly in the target species and the necessity of measuring different types of immune response when evaluating immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641101      PMCID: PMC2756844          DOI: 10.1128/CVI.00229-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

Review 1.  Epidemiology of selected mycobacteria that infect humans and other animals.

Authors:  D A Ashford; E Whitney; P Raghunathan; O Cosivi
Journal:  Rev Sci Tech       Date:  2001-04       Impact factor: 1.181

2.  Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.

Authors:  Anja W Olsen; Ann Williams; Limei M Okkels; Graham Hatch; Peter Andersen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Authors:  Jesper Davidsen; Ida Rosenkrands; Dennis Christensen; Anil Vangala; Daniel Kirby; Yvonne Perrie; Else Marie Agger; Peter Andersen
Journal:  Biochim Biophys Acta       Date:  2005-11-14

4.  Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

Authors:  Philip J Hogarth; Karen E Logan; H Martin Vordermeier; Mahavir Singh; R Glyn Hewinson; Mark A Chambers
Journal:  Vaccine       Date:  2005-04-08       Impact factor: 3.641

5.  Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.

Authors:  Jan A M Langermans; T Mark Doherty; Richard A W Vervenne; Tridia van der Laan; Konstantin Lyashchenko; Rena Greenwald; Else Marie Agger; Claus Aagaard; Horst Weiler; Dick van Soolingen; Wilfried Dalemans; Alan W Thomas; Peter Andersen
Journal:  Vaccine       Date:  2005-04-15       Impact factor: 3.641

6.  Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.

Authors:  L Holten-Andersen; T M Doherty; K S Korsholm; P Andersen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

7.  Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Authors:  Nick Andrews; Ray Borrow; Elizabeth Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

8.  A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

Authors:  William H H Reece; Margaret Pinder; Philip K Gothard; Paul Milligan; Kalifa Bojang; Tom Doherty; Magdalena Plebanski; Peter Akinwunmi; Simone Everaere; Katherine R Watkins; Gerald Voss; Nadia Tornieporth; Ali Alloueche; Brian M Greenwood; Kent E Kester; Keith P W J McAdam; Joe Cohen; Adrian V S Hill
Journal:  Nat Med       Date:  2004-03-14       Impact factor: 53.440

Review 9.  Tuberculosis vaccines: the past, present and future.

Authors:  Jun Wang; Zhou Xing
Journal:  Expert Rev Vaccines       Date:  2002-10       Impact factor: 5.217

Review 10.  Novel approaches to vaccine delivery.

Authors:  Derek T O'Hagan; Rino Rappuoli
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

View more
  10 in total

1.  Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Authors:  Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

2.  Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.

Authors:  Gareth J Jones; Sabine Steinbach; Derek Clifford; Susan L Baldwin; Gregory C Ireton; Rhea N Coler; Steven G Reed; H Martin Vordermeier
Journal:  Vaccine       Date:  2013-09-05       Impact factor: 3.641

3.  Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.

Authors:  A D White; L Sibley; M J Dennis; K Gooch; G Betts; N Edwards; A Reyes-Sandoval; M W Carroll; A Williams; P D Marsh; H McShane; S A Sharpe
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

4.  The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.

Authors:  Simone C de Cassan; Emily K Forbes; Alexander D Douglas; Anita Milicic; Bijender Singh; Puneet Gupta; Virander S Chauhan; Chetan E Chitnis; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

5.  The duration of antigen-stimulation significantly alters the diversity of multifunctional CD4 T cells measured by intracellular cytokine staining.

Authors:  Daryan A Kaveh; Adam O Whelan; Philip J Hogarth
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

6.  Effect of lipoarabinomannan from Mycobacterium avium subsp avium in Freund's incomplete adjuvant on the immune response of cattle.

Authors:  S B Colavecchia; A Jolly; B Fernández; A M Fontanals; E Fernández; S L Mundo
Journal:  Braz J Med Biol Res       Date:  2012-02-02       Impact factor: 2.590

7.  Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.

Authors:  Aneesh Thakur; Athina Andrea; Heidi Mikkelsen; Joshua S Woodworth; Peter Andersen; Gregers Jungersen; Claus Aagaard
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

8.  The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant used.

Authors:  D J Begg; O Dhungyel; A Naddi; N K Dhand; K M Plain; K de Silva; A C Purdie; R J Whittington
Journal:  Heliyon       Date:  2019-06-18

9.  Influence of Heterologous and Homologous Vaccines, and Their Components, on the Host Immune Response and Protection Against Experimental Caprine Paratuberculosis.

Authors:  Noive Arteche-Villasol; Daniel Gutiérrez-Expósito; Natalia Elguezabal; Iker A Sevilla; Raquel Vallejo; José Espinosa; María Del Carmen Ferreras; Julio Benavides; Valentín Pérez
Journal:  Front Vet Sci       Date:  2022-01-05

10.  T helper 17-associated cytokines are produced during antigen-specific inflammation in the mammary gland.

Authors:  Pascal Rainard; Patricia Cunha; Salim Bougarn; Angélina Fromageau; Christelle Rossignol; Florence B Gilbert; Patricia Berthon
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.